Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...
The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights ...
High-resolution analytical platforms, proteomics-driven workflows, and expanding CRO outsourcing reshape strategic priorities ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
AI and genetics are creating a 'seismic shift' in the pharmaceutical business, experts on Asian Financial Forum panel say ...
Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, today announced a new contract valued at up to £617,000 with a top-five pharmaceutical company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results